[15] [27] In October 2025, the FDA further expanded the indication for semaglutide (as Rybelsus) to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes who are at high risk for these events
reducing cardiovascular risk in adults with established cardiovascular disease (CVD)
Before injecting, always hold the syringe needle-up, tap the barrel to float bubbles to the top, and push the plunger until the air is expelled
providers, named compounding pharmacies, and flat pricing that never changes as your dose does
The 4 mm needle is still clinically validated for this group when injected at 90 degrees, but some users prefer slightly longer needles for confidence that the medication reaches deep enough into the subcutaneous tissue